Skip to main content
. 2018 Mar 12;13(3):e0193496. doi: 10.1371/journal.pone.0193496

Table 5. Strain-dependent differentially methylated CpGs/regions detected by both Illumina human MethylationEPIC probes and by MBD-seq.

EPIC1 MBD-seq1
ProbeID Gene3 Region4 Position (mm10) 3 Coef.2 Strain (P) logFC2 Strain (P)
Differentially methylated CpGs detected by EPIC probe at FDR 10%; replicated by MBD-seq
cg21064315 SZT2 3'UTR; Shore chr4:118.36 -0.82 5.5E-09 -2.0 1.7E-04
cg14945867 CNIH 1stExon; Island chr14:46.79 0.27 1.3E-06 6.0 1.2E-09
cg04546815 KANK4 Body chr4:98.78 0.34 1.6E-06 1.7 4.4E-04
cg10277781 CNIH 1stExon; Island chr14:46.79 0.35 1.9E-06 6.0 1.2E-09
cg00049718 CSDE1 5'UTR chr3:103.02 0.40 2.6E-06 6.8 9.8E-15
cg07211292 C20orf160 3'UTR; Island chr2:153.08 -0.46 5.0E-06 -1.5 1.4E-05
cg24255125 GRIK4 Body; Island chr9:42.52 -0.36 7.8E-06 -3.0 5.9E-09
cg03517030 MTCH2 1stExon; Island chr2:90.85 0.35 1.6E-05 6.7 2.3E-14
cg05781968 WNT5A Body; Island chr14:28.51 0.31 4.4E-05 2.3 1.0E-05
cg04154281 UBTF Body; Shore chr11:102.31 0.17 6.5E-05 0.7 0.03
cg06861375 ZNF697 Body; Island chr3:98.43 0.36 6.7E-05 4.5 2.8E-04
cg24959134 - - chr10:92.44 -0.33 9.4E-05 -2.4 0.01
cg06552810 - - chr2:106.19 0.26 1.1E-04 2.9 0.002
cg01663821 Shore chr3:98.94 0.19 1.3E-04 0.9 0.02
cg00597112 - - chr11:109.01 0.21 1.4E-04 0.5 0.002
cg26857408 UBTF Body; Shore chr11:102.31 0.24 2.1E-04 0.7 0.03
cg15172734 SLMAP 5'UTR; Shore chr14:26.53 -0.11 3.4E-04 -2.5 0.01
cg09990537 WNT5A 5'UTR; Shore chr14:28.51 0.17 3.4E-04 1.0 0.004
cg12849734 - - chr2:157.71 0.14 4.4E-04 0.9 0.01
cg21746387 NDUFA4L2 TSS1500; Shore chr10:127.51 -0.17 5.5E-04 -3.4 0.001
cg11382417 - - chr2:96.32 -0.21 6.0E-04 -4.7 1.3E-07
cg02865068 - Shore chr2:105.66 0.11 9.7E-04 2.9 0.04
cg14275842 CHRNE Body; Island chr11:70.62 0.18 0.001 1.0 0.005
cg02159996 GABRR1 5'UTR chr4:33.13 0.13 0.001 1.2 2.5E-04
cg00920372 - - chr19:45.33 -0.08 0.001 -1.5 8.8E-04
cg03422015 ERC1 Body chr6:119.69 0.04 0.001 1.1 0.02
cg04340318 - - chr4:86.04 0.16 0.001 2.3 0.001
cg14465355 DYNC1H1 Body; Shore chr12:110.64 0.06 0.001 0.6 0.02
cg15002641 SOX13 Body chr1:133.39 -0.10 0.001 -1.0 0.02
Differentially methylated regions detected by MBD-seq at FDR 10%; replicated by EPIC
cg05362127 WNT5A TSS200; Island chr14:28.51 0.33 0.002 2.3 9.4E-06
cg24142850 - - chr8:92.55 -0.09 0.005 -2.9 9.4E-05
cg15585318 WNT5A Body; Island chr14:28.51 0.22 0.006 1.8 2.1E-06
cg09595163 WNT5A Body; Island chr14:28.51 0.18 0.006 2.3 1.2E-05
cg13868216 BAIAP2L2 Body; Island chr15:79.26 0.11 0.01 1.6 1.8E-04
cg09972454 PDXDC1 Body; Shore chr4:147.94 -0.06 0.01 -2.9 1.5E-06
cg18120446 - Island chr5:41.75 0.01 0.02 -2.2 2.7E-08

1These are strain-dependent differentially methylated CpGs (EPIC microarray) and CpG regions (MBD-seq) based on a “false discovery threshold” (FDR) cutoff of 10% and replication at an uncorrected p-value threshold of 0.05.

2Coef. is the linear regression coefficient (i.e., difference in methylation relative to C57BL/6J; negative is lower methylation in DBA/2J; and positive is higher methylation in DBA/2J compared to C57BL/6J). LogFC is log2 fold difference in methylation (i.e., difference in methylation relative to DBA/2J; negative is lower methylation in DBA/2J; and positive is higher methylation in DBA/2J compared to C57BL/6J).

3CpG location in relation to gene features and CpG region based in probe annotations for the human methylation microarray. For most conserved regions, mouse annotations are analogous to humans.

4Chromosome and Megabase coordinate based on mm10 mouse reference genome